IRadimed Corporation (IRMD)
USD 52.33
(-1.26%)
USD 52.33
(-1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 13.46 Million | 10.04 Million | 11.25 Million | 5.81 Million | 10.23 Million | 7.37 Million |
| Net Income | 17.19 Million | 12.82 Million | 9.32 Million | 1.36 Million | 9.63 Million | 6.3 Million |
| Depreciation & Amortization | 765.18 Thousand | 670.67 Thousand | 1.4 Million | 1.33 Million | 1.24 Million | 1.1 Million |
| Deferred income taxes | -1.17 Million | 57.09 Thousand | 523.6 Thousand | 389.93 Thousand | -596.75 Thousand | -144.43 Thousand |
| Stock-based compensation | 2.18 Million | 1.39 Million | 1.45 Million | 3.96 Million | 1.85 Million | 1.76 Million |
| Change in working capital | -5.91 Million | -5.05 Million | -1.57 Million | -1.17 Million | -1.96 Million | -1.8 Million |
| Other non-cash items | 402.31 Thousand | 148.73 Thousand | 119.04 Thousand | -70.07 Thousand | 68.68 Thousand | 155.65 Thousand |
| Investing Cash Flow | -8 Million | -1.37 Million | 648.24 Thousand | 246.96 Thousand | 3.2 Million | 1.51 Million |
| Investments in PPE | -8 Million | -1.87 Million | -741.75 Thousand | -636.74 Thousand | -485.81 Thousand | -264.66 Thousand |
| Acquisitions | - | - | - | - | - | 36.35 Thousand |
| Investment purchases | - | - | - | - | - | -1.12 Million |
| Sales/Maturities of investments | - | 500 Thousand | 1.39 Million | 883.71 Thousand | 3.68 Million | 2.9 Million |
| Other Investing Activities | -566.65 Thousand | -551.97 Thousand | 1.13 Million | 689.97 Thousand | 3.56 Million | -36.35 Thousand |
| Financing Cash Flow | -13.65 Million | -12.7 Million | 24.42 Thousand | 522.48 Thousand | 2.02 Million | 929.87 Thousand |
| Debt repayment | - | -147.27 Thousand | - | - | - | - |
| Dividends payments | -13.22 Million | -12.55 Million | - | - | - | - |
| Common Stock Repurchased | -610.34 Thousand | -293.98 Thousand | -598.81 Thousand | -1.2 Million | -473.14 Thousand | -309.56 Thousand |
| Common Stock Issuance | 176.74 Thousand | 146.7 Thousand | 623.24 Thousand | 1.73 Million | 2.49 Million | 1.23 Million |
| Other Financing Activities | 176.74 Thousand | 147.27 Thousand | -598.81 Thousand | -1.2 Million | -473.14 Thousand | 929.87 Thousand |
| Accounts receivables | 841.91 Thousand | -8.24 Million | -575.54 Thousand | 2.69 Million | -3.11 Million | -446.89 Thousand |
| Accounts payables | -216.43 Thousand | 1.12 Million | 30.41 Thousand | -403.56 Thousand | 149.31 Thousand | 34.16 Thousand |
| Inventory | -7.46 Million | -1.3 Million | -393.31 Thousand | -282.9 Thousand | 123.68 Thousand | -121.59 Thousand |
| Other working capital | 932.43 Thousand | 3.36 Million | -637.71 Thousand | -3.17 Million | 874.2 Thousand | -1.27 Million |
| Cash at beginning of period | 57.96 Million | 61.99 Million | 50.06 Million | 43.48 Million | 28.02 Million | 18.2 Million |
| Cash at end of period | 49.76 Million | 57.96 Million | 61.99 Million | 50.06 Million | 43.48 Million | 28.02 Million |
| Capital Expenditure | -8 Million | -1.87 Million | -741.75 Thousand | -636.74 Thousand | -485.81 Thousand | -264.66 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.19 Million | -4.03 Million | 11.93 Million | 6.58 Million | 15.45 Million | 9.82 Million |
| Free Cash Flow | 5.45 Million | 8.16 Million | 10.51 Million | 5.18 Million | 9.74 Million | 7.11 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.04 Million | 4.9 Million | 4.13 Million | 4.53 Million | 17.19 Million | 5.06 Million |
| Depreciation & Amortization | 197.57 Thousand | 199.13 Thousand | 226.08 Thousand | 205.37 Thousand | 765.18 Thousand | 189.89 Thousand |
| Deferred income taxes | 717.65 Thousand | -1.63 Million | 917.37 Thousand | -69.04 Thousand | -1.17 Million | -37.35 Thousand |
| Stock-based compensation | 629.96 Thousand | 609.09 Thousand | 628.64 Thousand | 551.06 Thousand | 2.18 Million | 533.74 Thousand |
| Change in working capital | -411.51 Thousand | 2.43 Million | -2.02 Million | -1.34 Million | -5.91 Million | -4.38 Million |
| Other non-cash items | 2.93 Million | -246.33 Thousand | 2.39 Million | 33.02 Thousand | 402.31 Thousand | 27.15 Thousand |
| Investing Cash Flow | -4.01 Million | -1.26 Million | -478.8 Thousand | -632.81 Thousand | -8 Million | -439.02 Thousand |
| Investments in PPE | -3.46 Million | -1.26 Million | -478.8 Thousand | -632.81 Thousand | -8 Million | -439.02 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -545.19 Thousand | -135.49 Thousand | -208.23 Thousand | -100.91 Thousand | -566.65 Thousand | -130.93 Thousand |
| Financing Cash Flow | -1.91 Million | -1.96 Million | -8.03 Million | -262.59 Thousand | -13.65 Million | -31.37 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -1.9 Million | -1.89 Million | -7.97 Million | -13.22 Million | -13.22 Million | - |
| Common Stock Repurchased | 63.87 Thousand | - | -63.87 Thousand | -431.99 Thousand | -610.34 Thousand | -31.37 Thousand |
| Common Stock Issuance | -3296.00 | 3296.00 | - | 169.4 Thousand | 176.74 Thousand | 2.00 |
| Other Financing Activities | -78.41 Thousand | -63.94 Thousand | -63.87 Thousand | 169.4 Thousand | 176.74 Thousand | 2.00 |
| Accounts receivables | 1.69 Million | 1.01 Million | -764.32 Thousand | 498.85 Thousand | 841.91 Thousand | -1.67 Million |
| Accounts payables | 289.05 Thousand | -122.55 Thousand | -640.32 Thousand | -736.08 Thousand | -216.43 Thousand | -1.18 Million |
| Inventory | 699.52 Thousand | 485.63 Thousand | 93.05 Thousand | -1.33 Million | -7.46 Million | -1.91 Million |
| Other working capital | -343.3 Thousand | 1.05 Million | -714.89 Thousand | 227.17 Thousand | 932.43 Thousand | 397.64 Thousand |
| Cash at beginning of period | 48.53 Million | 45.12 Million | 49.76 Million | 46.74 Million | 57.96 Million | 45.82 Million |
| Cash at end of period | 51.72 Million | 48.53 Million | 45.12 Million | 49.76 Million | 49.76 Million | 46.74 Million |
| Capital Expenditure | -3.46 Million | -1.26 Million | -478.8 Thousand | -632.81 Thousand | -8 Million | -439.02 Thousand |
| Effect of forex changes on cash | - | - | - | 1.29 Million | - | - |
| Net cash flow / Change in cash | 3.18 Million | 3.4 Million | -4.63 Million | 3.01 Million | -8.19 Million | 922.29 Thousand |
| Free Cash Flow | 5.64 Million | 5.36 Million | 3.4 Million | 3.27 Million | 5.45 Million | 953.66 Thousand |
4442
REN
300316
0432
DKNG1
INTAF